Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Price / Earnings (ntm)

Rigel Pharmaceuticals Price / Earnings (ntm) Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Price / Earnings (ntm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Rigel Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $521m a 35.88% increase of 187m year over year
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $406m a 41.78% increase of 169m year over year
View Chart On Koyfin